Zura Bio Limited
ZURA
$1.23
$0.086.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -51.15% | 113.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.57% | 64.29% | |||
| Operating Income | 18.57% | -64.29% | |||
| Income Before Tax | 34.19% | -100.43% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 34.19% | -100.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 34.19% | -100.43% | |||
| EBIT | 18.57% | -64.29% | |||
| EBITDA | 18.58% | -64.27% | |||
| EPS Basic | 62.12% | -55.44% | |||
| Normalized Basic EPS | 36.80% | -72.01% | |||
| EPS Diluted | 62.12% | -55.44% | |||
| Normalized Diluted EPS | 36.80% | -72.01% | |||
| Average Basic Shares Outstanding | 4.14% | 16.53% | |||
| Average Diluted Shares Outstanding | 4.14% | 16.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||